Description: Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. It offers its various products in various therapeutic areas, including anti-allergic, anti-diabetic, antihistamine, anti-infective, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, neurology, pain/fever/inflammation, pediatrics, psychiatry, respiratory, urology, women's health, central nervous system, autoimmune disorders, and gastrointestinal. The company also provides multivitamins, vitamins/minerals, antibiotics, steroids, vaccines, and consumer healthcare products. It sells its products through a network of independent distributors primarily under the Minipress XL, Folvite, Magnex, Eliquis, Gelusil, Lyrica, Ovral L, Citralka, Prevenar 13, Autrin, Zavicefta, Wysolone, Xeljanz, Corex, Mucaine, Becosules, Ativan, Neksium, Meronem, And Dolonex brand names. Pfizer Limited was incorporated in 1950 and is headquartered in Mumbai, India.
Home Page: www.pfizerindia.com
The Capital
Mumbai,
400051
India
Phone:
91 22 6693 2000
Officers
| Name | Title |
|---|---|
| Mr. Sridhar Subramaniam | CEO, MD, Lead of Essential Health Portfolio & Director |
| Mr. Milind Anil Patil | CFO, Exec. Director of Fin. & Exec. Director |
| Mr. Prajeet Nair | Compliance Officer & Company Sec. |
| Mr. Samir Salauddin Kazi | Exec. Director & Exec. Director of Legal |
| Mr. Sharad Goswami | Sr. Director of Public Affairs |
| Ms. Shilpi Singh | Director of HR |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 37.535 |
| Price-to-Book MRQ: | 6.8762 |
| Price-to-Sales TTM: | 8.1666 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2489 |